Fundraising FoxOmnes Capital — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Qantev builds AI software that helps large insurers manage and optimize their health and life claims operations.
AI & Machine LearningDigital HealthInsurTechParis, FR
Tarik Dadi(CEO)inHadrien De March(CTO)in
Co-investorsBlossom CapitalElaiaEntrepreneur FirstPSL Innovation FundSTATION FRAISE
Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation.
BiotechDigital Health
Co-investors3B Future Health FundCTI Life Sciences Fund L.P.adMare BioInnovationsPanacea VentureSeventure Partners
Qubit Pharmaceuticals develops novel drug candidates using quantum physics, AI, and computational chemistry through its ATLAS platform for high-precision molecular simulation, modeling, and molecule generation.
AI & Machine LearningBiotechQuantum ComputingParis, FR
Robert Marino(CEO)in
Co-investorsQuantonationXAnge
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.